NCT03299894

Brief Summary

The delayed administration of an adequate antimicrobial therapy is a strong predictor of impaired outcome in patients with bacterial sepsis. Therefore, the current Surviving Sepsis Campaign guidelines (2016) recommend that administration of intravenous antimicrobials be initiated within one hour following the recognition of sepsis or septic shock. The quick Sepsis-related Organ Failure Assessment (qSOFA) score is a new bedside tool which has been recently proposed by the Third International Sepsis Consensus Definitions Task Force (Sepsis-3) to identify patients with suspected infection who are at greater risk for a poor outcome outside the Intensive Care Unit (ICU). It uses three criteria, assigning one point for low systolic blood pressure (SBP ≤100 mmHg), high respiratory rate (≥22 breaths per min) and altered mentation (Glasgow coma scale \<15). The score ranges from 0 to 3 points. A qSOFA value ≥2 points is associated with a greater risk of death or prolonged ICU stay, these outcomes being more common in infected patients who may be septic than in those with uncomplicated infection. The definite goal of qSOFA is to hasten the management and thus improve the outcome of patients at risk of sepsis or septic shock. Many patients admitted to the hospital for bacterial sepsis or septic shock are initially managed in the Emergency Department (ED). This study aims at investigating whether the routine calculation of qSOFA at patient triage may hasten the initiation of antimicrobial therapy in patients admitted to the ED with suspected or proven bacterial infection, especially in those with subsequent criteria for sepsis or septic shock (Sepsis-3 definition).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
780

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 3, 2017

Completed
9 days until next milestone

Study Start

First participant enrolled

October 12, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2018

Completed
Last Updated

August 1, 2018

Status Verified

July 1, 2018

Enrollment Period

8 months

First QC Date

September 25, 2017

Last Update Submit

July 31, 2018

Conditions

Keywords

SepsisShock, septicEmergency service, hospitalAnti-infective agentsOutcome assessment

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients who receive a first dose of antimicrobial agent

    Proportion of patients with criteria for sepsis or septic shock (Sepsis-3 definition) who receive a first dose of antimicrobial agent within one hour following triage in the emergency department.

    one hour

Secondary Outcomes (8)

  • Proportion of patients who receive a first dose of adequate antimicrobial agent

    one hour

  • Proportion of patients who receive a first dose of antimicrobial agent

    three hours

  • Proportion of patients who receive a first dose of adequate antimicrobial agent

    three hours

  • Proportion of patients with a decrease in SOFA score value ≥ 1 point

    two days

  • Proportion of patients requiring an admission to the Intensive Care Unit

    two days

  • +3 more secondary outcomes

Study Arms (2)

systematic calculation of qSOFA

EXPERIMENTAL

Usual procedure for patient triage AND systematic calculation of qSOFA at Emergency Department triage in patients admitted with a suspected or proven bacterial infection.

Procedure: systematic calculation of qSOFA

no systematic calculation of qSOFA

NO INTERVENTION

Usual procedures for patient triage at Emergency Department admission and management of suspected or proven bacterial infection. No systematic calculation of qSOFA.

Interventions

calculation of qSOFA for each patient

systematic calculation of qSOFA

Eligibility Criteria

Age18 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Suspected or proven bacterial infection at emergency department triage

You may not qualify if:

  • Imminent death
  • Pregnancy
  • Breast-feeding
  • For patients managed by a medicalized pre-hospital emergency team before ED admission : administration of a first dose of antimicrobial agent before ED admission
  • Lack of coverage by the public health insurance system
  • Patient's refusal for study enrollment
  • Lack of confirmed bacterial infection (i.e., documented either clinically, microbiologically or by imaging procedures) in patients with a suspected bacterial infection at emergency departement triage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regional Hospital center of Orleans

Orléans, 45067, France

Location

Related Publications (2)

  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.

    PMID: 26903338BACKGROUND
  • Petit J, Passerieux J, Maitre O, Guerin C, Rozelle C, Cordeau O, Cassonnet A, Malet A, Boulain T, Barbier F; qSOFAST study group. Impact of a qSOFA-based triage procedure on antibiotic timing in ED patients with sepsis: A prospective interventional study. Am J Emerg Med. 2020 Mar;38(3):477-484. doi: 10.1016/j.ajem.2019.05.022. Epub 2019 May 10.

MeSH Terms

Conditions

Bacterial InfectionsSepsisShock, SepticEmergencies

Condition Hierarchy (Ancestors)

Bacterial Infections and MycosesInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShockDisease Attributes

Study Officials

  • Julien PASSERIEUX, MD

    Regional Hospital Center of Orleans

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Model Details: Patients will be prospectively included at Emergency Department triage during 2 consecutive 6-month periods (1-month wash-out interlude between the 2 inclusion periods): * First inclusion period: usual procedures for patient triage at Emergency Department admission and management of suspected or proven bacterial infection. * Second inclusion period: usual procedure for patient triage at Emergency Department admission PLUS routine calculation of qSOFA in all patients admitted to the Emergency Department with a suspected or proven bacterial infection. Patients with a qSOFA value ≥2 will be directly and immediately notified to Emergency Department physicians by triage nurses.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2017

First Posted

October 3, 2017

Study Start

October 12, 2017

Primary Completion

June 10, 2018

Study Completion

June 10, 2018

Last Updated

August 1, 2018

Record last verified: 2018-07

Locations